{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T17:54:55Z","timestamp":1777398895170,"version":"3.51.4"},"reference-count":28,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2015,6,26]],"date-time":"2015-06-26T00:00:00Z","timestamp":1435276800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European J of Haematology"],"published-print":{"date-parts":[[2016,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Next\u2010generation sequencing (<jats:styled-content style=\"fixed-case\">NGS<\/jats:styled-content>) is becoming increasingly used for diagnostic mutation analysis in myeloid neoplasms and may also represent a feasible technique in mastocytosis. However, detection of the <jats:italic><jats:styled-content style=\"fixed-case\">KIT<\/jats:styled-content><\/jats:italic> <jats:styled-content style=\"fixed-case\">D<\/jats:styled-content>816<jats:styled-content style=\"fixed-case\">V<\/jats:styled-content> mutation requires a highly sensitive method in most patients due to the typically low mutation levels. In this study, we established an <jats:styled-content style=\"fixed-case\">NGS<\/jats:styled-content>\u2010based <jats:italic><jats:styled-content style=\"fixed-case\">KIT<\/jats:styled-content><\/jats:italic> mutation analysis and analyzed the sensitivity of <jats:styled-content style=\"fixed-case\">D<\/jats:styled-content>816<jats:styled-content style=\"fixed-case\">V<\/jats:styled-content> detection using the <jats:styled-content style=\"fixed-case\">I<\/jats:styled-content>on <jats:styled-content style=\"fixed-case\">T<\/jats:styled-content>orrent platform. Eighty\u2010two individual <jats:styled-content style=\"fixed-case\">NGS<\/jats:styled-content> analyses were included in the study. All samples were also analyzed using highly sensitive <jats:italic><jats:styled-content style=\"fixed-case\">KIT<\/jats:styled-content><\/jats:italic> <jats:styled-content style=\"fixed-case\">D<\/jats:styled-content>816<jats:styled-content style=\"fixed-case\">V<\/jats:styled-content> mutation\u2010specific <jats:styled-content style=\"fixed-case\">qPCR<\/jats:styled-content>. Measurements of the background level in <jats:styled-content style=\"fixed-case\">D<\/jats:styled-content>816<jats:styled-content style=\"fixed-case\">V<\/jats:styled-content>\u2010negative samples supported a cutoff for positivity of 0.2% in three different <jats:styled-content style=\"fixed-case\">NGS<\/jats:styled-content> panels. Clinical samples from patients with <jats:styled-content style=\"fixed-case\">SM<\/jats:styled-content> that tested positive using <jats:styled-content style=\"fixed-case\">qPCR<\/jats:styled-content> with a <jats:styled-content style=\"fixed-case\">D<\/jats:styled-content>816<jats:styled-content style=\"fixed-case\">V<\/jats:styled-content> allele burden &gt;0.2% also tested positive using <jats:styled-content style=\"fixed-case\">NGS<\/jats:styled-content>. Samples that tested positive using <jats:styled-content style=\"fixed-case\">qPCR<\/jats:styled-content> with an allele burden &lt;0.2% tested negative using <jats:styled-content style=\"fixed-case\">NGS<\/jats:styled-content>. We thereby demonstrate that caution should be taken when using the potentially very sensitive <jats:styled-content style=\"fixed-case\">NGS<\/jats:styled-content> technique for <jats:italic><jats:styled-content style=\"fixed-case\">KIT<\/jats:styled-content><\/jats:italic> <jats:styled-content style=\"fixed-case\">D<\/jats:styled-content>816<jats:styled-content style=\"fixed-case\">V<\/jats:styled-content> mutation analysis in mastocytosis, as many patients with <jats:styled-content style=\"fixed-case\">SM<\/jats:styled-content> have <jats:styled-content style=\"fixed-case\">D<\/jats:styled-content>816<jats:styled-content style=\"fixed-case\">V<\/jats:styled-content> mutation levels below the detection limit of <jats:styled-content style=\"fixed-case\">NGS<\/jats:styled-content>. A dedicated and highly sensitive <jats:italic><jats:styled-content style=\"fixed-case\">KIT<\/jats:styled-content><\/jats:italic> <jats:styled-content style=\"fixed-case\">D<\/jats:styled-content>816<jats:styled-content style=\"fixed-case\">V<\/jats:styled-content> mutation analysis therefore remains important in mastocytosis diagnostics.<\/jats:p>","DOI":"10.1111\/ejh.12601","type":"journal-article","created":{"date-parts":[[2015,6,19]],"date-time":"2015-06-19T11:08:55Z","timestamp":1434712135000},"page":"381-388","source":"Crossref","is-referenced-by-count":15,"title":["Targeted ultradeep next\u2010generation sequencing as a method for <i><scp>KIT<\/scp><\/i><scp>D<\/scp>816<scp>V<\/scp> mutation analysis in mastocytosis"],"prefix":"10.1111","volume":"96","author":[{"given":"Thomas","family":"Kristensen","sequence":"first","affiliation":[{"name":"Department of Pathology Odense University Hospital Odense Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sigurd","family":"Broesby\u2010Olsen","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Allergy Centre Odense University Hospital Odense Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanne","family":"Vestergaard","sequence":"additional","affiliation":[{"name":"Department of Hematology Odense University Hospital Odense Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carsten","family":"Bindslev\u2010Jensen","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Allergy Centre Odense University Hospital Odense Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael Boe","family":"M\u00f8ller","sequence":"additional","affiliation":[{"name":"Department of Pathology Odense University Hospital Odense Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"the Mastocytosis Centre Odense University Hospital (MastOUH)","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2015,6,26]]},"reference":[{"key":"e_1_2_6_2_1","first-page":"54","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Horny HP","year":"2008"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2013.02.019"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.23672"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-04-015545"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-02-205237"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.92.23.10560"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2004.04.046"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-11-078097"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2014.11.029"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2015.24"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12194"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2013.086686"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2014.12.006"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2012.29"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-04-496448"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmoldx.2010.10.004"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2014.06.031"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/all.12436"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-013-1964-1"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/all.12409"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2362.2007.01807.x"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-01-0246"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0301-472X(03)00112-7"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.12128"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-11-3816"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmoldx.2014.02.005"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmoldx.2013.03.003"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.86.23.9253"}],"container-title":["European Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fejh.12601","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ejh.12601","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T19:45:57Z","timestamp":1696275957000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ejh.12601"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,26]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["10.1111\/ejh.12601"],"URL":"https:\/\/doi.org\/10.1111\/ejh.12601","archive":["Portico"],"relation":{},"ISSN":["0902-4441","1600-0609"],"issn-type":[{"value":"0902-4441","type":"print"},{"value":"1600-0609","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,26]]}}}